![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF12 |
Gene summary for ZNF12 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF12 | Gene ID | 7559 |
Gene name | zinc finger protein 12 | |
Gene Alias | GIOT-3 | |
Cytomap | 7p22.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | P17014 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7559 | ZNF12 | HCC1_Meng | Human | Liver | HCC | 3.11e-43 | 3.90e-02 | 0.0246 |
7559 | ZNF12 | HCC2_Meng | Human | Liver | HCC | 5.26e-08 | 4.30e-02 | 0.0107 |
7559 | ZNF12 | HCC2 | Human | Liver | HCC | 4.14e-07 | 2.94e+00 | 0.5341 |
7559 | ZNF12 | S014 | Human | Liver | HCC | 7.74e-05 | 2.66e-01 | 0.2254 |
7559 | ZNF12 | S016 | Human | Liver | HCC | 3.12e-04 | 3.03e-01 | 0.2243 |
7559 | ZNF12 | S027 | Human | Liver | HCC | 1.48e-09 | 7.20e-01 | 0.2446 |
7559 | ZNF12 | S028 | Human | Liver | HCC | 4.75e-28 | 9.13e-01 | 0.2503 |
7559 | ZNF12 | S029 | Human | Liver | HCC | 4.09e-17 | 7.89e-01 | 0.2581 |
7559 | ZNF12 | C21 | Human | Oral cavity | OSCC | 6.29e-10 | 3.47e-01 | 0.2678 |
7559 | ZNF12 | C30 | Human | Oral cavity | OSCC | 7.36e-17 | 6.08e-01 | 0.3055 |
7559 | ZNF12 | C38 | Human | Oral cavity | OSCC | 4.02e-08 | 5.92e-01 | 0.172 |
7559 | ZNF12 | C43 | Human | Oral cavity | OSCC | 3.36e-05 | 1.36e-01 | 0.1704 |
7559 | ZNF12 | C46 | Human | Oral cavity | OSCC | 2.54e-04 | 1.58e-01 | 0.1673 |
7559 | ZNF12 | C51 | Human | Oral cavity | OSCC | 4.09e-02 | 2.31e-01 | 0.2674 |
7559 | ZNF12 | C08 | Human | Oral cavity | OSCC | 6.15e-21 | 3.98e-01 | 0.1919 |
7559 | ZNF12 | LP15 | Human | Oral cavity | LP | 4.26e-02 | 3.20e-01 | 0.2174 |
7559 | ZNF12 | SYSMH1 | Human | Oral cavity | OSCC | 3.77e-08 | 2.15e-01 | 0.1127 |
7559 | ZNF12 | SYSMH2 | Human | Oral cavity | OSCC | 4.37e-07 | 1.90e-01 | 0.2326 |
7559 | ZNF12 | SYSMH3 | Human | Oral cavity | OSCC | 2.70e-03 | 1.77e-01 | 0.2442 |
7559 | ZNF12 | male-WTA | Human | Thyroid | PTC | 7.11e-09 | 6.13e-02 | 0.1037 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZNF12 | ECC | Skin | ADJ | STEAP2,BMT2,SHLD1, etc. | 9.02e-02 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF12 | SNV | Missense_Mutation | rs369502322 | c.631C>T | p.Arg211Cys | p.R211C | P17014 | protein_coding | deleterious(0.01) | benign(0.28) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
ZNF12 | SNV | Missense_Mutation | novel | c.686A>G | p.Asp229Gly | p.D229G | P17014 | protein_coding | tolerated(0.06) | benign(0.001) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF12 | SNV | Missense_Mutation | c.575N>G | p.Phe192Cys | p.F192C | P17014 | protein_coding | tolerated(0.49) | benign(0.007) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF12 | SNV | Missense_Mutation | novel | c.1958N>A | p.Arg653Lys | p.R653K | P17014 | protein_coding | deleterious(0.04) | probably_damaging(0.994) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF12 | SNV | Missense_Mutation | c.1454N>T | p.Arg485Ile | p.R485I | P17014 | protein_coding | tolerated(0.18) | possibly_damaging(0.81) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF12 | SNV | Missense_Mutation | novel | c.1138N>T | p.Pro380Ser | p.P380S | P17014 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF12 | SNV | Missense_Mutation | c.200N>T | p.Trp67Leu | p.W67L | P17014 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-BG-A0LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ZNF12 | SNV | Missense_Mutation | novel | c.343A>G | p.Asn115Asp | p.N115D | P17014 | protein_coding | tolerated(0.43) | benign(0) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF12 | SNV | Missense_Mutation | c.1926N>A | p.Phe642Leu | p.F642L | P17014 | protein_coding | deleterious(0.02) | probably_damaging(0.994) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF12 | SNV | Missense_Mutation | c.1698N>G | p.Ile566Met | p.I566M | P17014 | protein_coding | tolerated(0.15) | possibly_damaging(0.877) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |